| Title |
|
|
|
Dipeptidyl peptidase IV-activated prodrugs of anti-varicella zoster virus bicyclic nucleoside analogues containing different self-cleavage spacer systems
|
|
| Author |
|
|
|
|
|
| Abstract |
|
|
|
| A new type of double prodrug of the antiviral family of bicyclic nucleoside analogues (BCNA) bearing cyclization self-cleavage spacers between the Val-Pro dipeptide sequence as well as the parent compound were synthesized and evaluated with regard to activation by the DPPIV/CD26 enzyme and for their stability in human and bovine serum. In buffer solution, carbamate and ester prodrugs were found to be chemically stable. Most prodrugs containing a dipeptidyl linker efficiently converted into the BCNA parent drug. In contrast, the Val-Pro alkyldiamino prodrugs converted predominantly into their alkyldiamino prodrug intermediates in the presence of CD26 and human serum. A marked increase in water solubility was observed for all prodrugs. In contrast to the parent compound, a tetrapeptide prodrug containing the Val-Val dipeptide as a self-cleavage spacer released substantial amounts of the BCNA parent drug at the basolateral side of Caco-2 cell cultures and exhibited 15- to 20-fold increased bioavailability in mice relative to the poorly bioavailable parent compound. | |
|
| Language |
|
|
|
English
|
|
| Source (journal) |
|
|
|
ChemMedChem. - Place of publication unknown |
|
| Publication |
|
|
|
Place of publication unknown : 2012
|
|
| ISSN |
|
|
|
1860-7179 [print]
1860-7187 [online]
|
|
| Volume/pages |
|
|
|
7:9(2012), p. 1612-1622
|
|
| ISI |
|
|
|
000308042000011
|
|
| Full text (Publisher's DOI) |
|
|
| |
|
| Full text (publisher's version - intranet only) |
|
|
| |
|